AU1329700A - Method of interfering with cell proliferation - Google Patents
Method of interfering with cell proliferationInfo
- Publication number
- AU1329700A AU1329700A AU13297/00A AU1329700A AU1329700A AU 1329700 A AU1329700 A AU 1329700A AU 13297/00 A AU13297/00 A AU 13297/00A AU 1329700 A AU1329700 A AU 1329700A AU 1329700 A AU1329700 A AU 1329700A
- Authority
- AU
- Australia
- Prior art keywords
- interfering
- cell proliferation
- proliferation
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1777—Integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10649198P | 1998-10-30 | 1998-10-30 | |
US60106491 | 1998-10-30 | ||
PCT/US1999/025359 WO2000026342A1 (en) | 1998-10-30 | 1999-10-29 | Method of interfering with cell proliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1329700A true AU1329700A (en) | 2000-05-22 |
Family
ID=22311691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13297/00A Abandoned AU1329700A (en) | 1998-10-30 | 1999-10-29 | Method of interfering with cell proliferation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1329700A (en) |
WO (1) | WO2000026342A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6955924B2 (en) | 1994-10-04 | 2005-10-18 | Biostratum, Inc. | Laminin chains: diagnostic uses |
EP1280553A2 (en) * | 2000-05-12 | 2003-02-05 | Fibrogen, Inc. | Methods of affecting laminin 5 processing |
JP2008502588A (en) * | 2003-12-12 | 2008-01-31 | ノボ ノルディスク アクティーゼルスカブ | Laminin-5 modulator and use thereof |
US7875277B2 (en) | 2004-01-27 | 2011-01-25 | The Dept. of Veterans Affairs Office of The General Counsel | Compositions and methods for inhibiting squamous cell carcinoma |
US7323551B2 (en) | 2004-01-27 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for inhibiting squamous cell carcinoma |
WO2007114851A1 (en) * | 2006-04-04 | 2007-10-11 | The Board Of Trustees Of The University Of Illinois | Methods and compositions to induce cell death of invasive tumors |
EP2291402B1 (en) | 2008-06-18 | 2015-11-04 | Karl Tryggvason | Antibodies against domains of laminin-332 |
EP2198884A1 (en) | 2008-12-18 | 2010-06-23 | Centre National de la Recherche Scientifique (CNRS) | Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5 |
US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
WO2015050663A1 (en) | 2013-10-01 | 2015-04-09 | Mayo Foundation For Medical Education And Research | Methods for treating cancer in patients with elevated levels of bim |
WO2015179654A1 (en) * | 2014-05-22 | 2015-11-26 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti b7-h1 antibodies |
US10517875B2 (en) | 2014-07-23 | 2019-12-31 | Mayo Foundation for Medical Engineering and Research | Targeting DNA-PKcs and B7-H1 to treat cancer |
US10875923B2 (en) | 2015-10-30 | 2020-12-29 | Mayo Foundation For Medical Education And Research | Antibodies to B7-H1 |
-
1999
- 1999-10-29 AU AU13297/00A patent/AU1329700A/en not_active Abandoned
- 1999-10-29 WO PCT/US1999/025359 patent/WO2000026342A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000026342A1 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5493201A (en) | Method for introduction of molecules into cells | |
AU2193500A (en) | Methods of preparing prismatic cells and prismatic cells prepared by such methods | |
AU1163700A (en) | Method for eliminating static electricity | |
AU3026399A (en) | An enzymatic oil-degumming process | |
AU1824600A (en) | Low oxygen culturing of cells | |
AU1610299A (en) | Method of cancer cell detection | |
AU6111699A (en) | Novel method and compounds | |
AU5170900A (en) | Cell proliferation inhibitors | |
AU6266398A (en) | Method of preparing electrochemical cells | |
AU3769097A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AU1329700A (en) | Method of interfering with cell proliferation | |
AU4040499A (en) | Electrochemical cell | |
AU2832399A (en) | B cell inhibitors | |
AU5124699A (en) | Molecules associated with cell proliferation | |
AU4697600A (en) | Methods for increasing t cell proliferation | |
AU7638498A (en) | Cyanoguanidines as cell proliferation inhibitors | |
AU6083898A (en) | Method for the manufacture of photovoltaic cell | |
AUPO235996A0 (en) | Method of cell culture | |
AU1563900A (en) | Depositing method and arrangement | |
AU2590399A (en) | Method of promoting hepatic cell proliferation | |
EP1038027A4 (en) | Decreasing cell proliferation by decreasing levels of pp5 | |
AU6634298A (en) | Biosensor for cells | |
AU3459497A (en) | Cancer cell proliferation inhibitors | |
AUPO129496A0 (en) | Photoelectrochemical cell | |
AU7625600A (en) | Electrochemical cell and cell assembly process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |